Merck KGaA (FRA:MRK) has been given a €105.00 ($123.53) target price by equities research analysts at Independent Research GmbH in a report issued on Thursday. The brokerage presently has a “neutral” rating on the healthcare company’s stock.

Several other equities research analysts also recently commented on MRK. J P Morgan Chase & Co set a €100.00 ($117.65) price objective on shares of Merck KGaA and gave the stock a “neutral” rating in a research note on Friday, September 29th. Oddo Bhf set a €125.00 ($147.06) price objective on shares of Merck KGaA and gave the stock a “buy” rating in a research note on Friday, September 29th. Warburg Research set a €115.00 ($135.29) price objective on shares of Merck KGaA and gave the stock a “buy” rating in a research note on Monday. Citigroup Inc. set a €123.00 ($144.71) price objective on shares of Merck KGaA and gave the stock a “buy” rating in a research note on Monday. Finally, Deutsche Bank AG set a €106.00 ($124.71) price objective on shares of Merck KGaA and gave the stock a “neutral” rating in a research note on Friday, August 4th. Thirteen investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of €109.43 ($128.75).

Shares of Merck KGaA (MRK) traded down 1.096% during midday trading on Thursday, reaching €95.715. 498 shares of the company’s stock were exchanged. The firm has a market cap of €41.61 billion and a PE ratio of 24.952. The stock’s 50-day moving average is €94.82 and its 200 day moving average is €101.88. Merck KGaA has a one year low of €89.00 and a one year high of €115.00.

TRADEMARK VIOLATION WARNING: This piece was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/10/05/independent-research-gmbh-reiterates-105-00-price-target-for-merck-kgaa-mrk.html.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.